Trabectedin or Dacarbazine in Patients With Advanced Liposarcoma or Leiomyosarcoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Overall Survival and Histology-Specific Subgroup Analyses From a Phase 3, Randomized Controlled Study of Trabectedin or Dacarbazine in Patients With Advanced Liposarcoma or Leiomyosarcoma
Cancer 2019 Jun 07;[EPub Ahead of Print], S Patel, M von Mehren, DR Reed, P Kaiser, J Charlson, CW Ryan, D Rushing, M Livingston, A Singh, R Seth, C Forscher, G D'Amato, SP Chawla, S McCarthy, G Wang, T Parekh, R Knoblauch, ML Hensley, RG Maki, GD DemetriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.